New drugs in respiratory disorders: I.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000336:Aerosols; D001249:Asthma / Q000517:prevention & control; D001623:Betamethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D007665:Ketotifen / Q000627:therapeutic use; D008134:Long-Term Care; D008171:Lung Diseases / Q000209:etiology; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D011239:Prednisolone / Q000627:therapeutic use; D012120:Respiration Disorders / Q000188:drug therapy*; D013806:Theophylline / Q000008:administration & dosage
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D001623:Betamethasone; D011239:Prednisolone; D013806:Theophylline; D009241:Ipratropium; D004205:Cromolyn Sodium; D007665:Ketotifen